Conmed (CNMD) Gross Profit (2010 - 2026)

Conmed's Gross Profit history runs 17 years deep, the most recent figure standing at $183.4 million for Q1 2026.

• Quarterly Gross Profit rose 3.2% year-over-year to $183.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $756.2 million (up 2.35% YoY) and the FY2025 annual result came in at $750.5 million, up 2.38% from the prior year.
• Gross Profit was $183.4 million for Q1 2026 at Conmed, down from $218.3 million in the prior quarter.
• Across five years, Gross Profit topped out at $218.3 million in Q4 2025 and bottomed at $131.9 million in Q4 2022.
• A 5-year average of $171.4 million and a median of $172.0 million in 2024 frame the typical range for Gross Profit.
• Annual changes were most pronounced in 2022 — Gross Profit slipped 15.39% — and 2023, when it surged 38.16%.
• Conmed's Gross Profit stood at $131.9 million in 2022, then jumped by 38.16% to $182.2 million in 2023, then climbed by 8.88% to $198.3 million in 2024, then gained by 10.05% to $218.3 million in 2025, then dropped by 15.96% to $183.4 million in 2026.
• Business Quant data shows CNMD's Gross Profit at $183.4 million in Q1 2026, $218.3 million in Q4 2025, and $166.1 million in Q3 2025.